Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia by Schneider, P, Crump, NT, Arentsen-Peters, STCJM, Smith, AL, Hagelaar, R, Adriaanse, FRS, Bos, RS, de Jong, A, Nierkens, S, Koopmans, B, Milne, TA, Pieters, R, Stam, RW

Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis by Agraz-Doblas, A, Bueno, C, Bashford-Rogers, R, Roy, A, Schneider, P, Bardini, M, Ballerini, P, Cazzaniga, G, Moreno, T, Revilla, C, Gut, M, Valsecchi, MG, Roberts, I, Pieters, R, De Lorenzo, P, Varela, I, Menendez, P, Stam, RW